Effect of inflammatory bowel disease treatments on patients with diabetes mellitus.

Bower, Joshua Ashley Jack; O'Flynn, Lauren; Kakad, Rakhi; Aldulaimi, David

Bower, Joshua Ashley Jack; O'Flynn, Lauren; Kakad, Rakhi; Aldulaimi, David.

Afiliación

Bower JAJ; Department of Gastroenterology, South Warwickshire Foundation Trust, Warwick CV34 5BW, United Kingdom.
O'Flynn L; Department of Gastroenterology, South Warwickshire Foundation Trust, Warwick CV34 5BW, United Kingdom. l.oflynn@doctors.org.uk.
Kakad R; Department of Endocrinology, South Warwickshire Foundation Trust, Warwick CV34 5BW, United Kingdom.
Aldulaimi D; Department of Gastroenterology, South Warwickshire Foundation Trust, Warwick CV34 5BW, United Kingdom.

World J Diabetes ; 12(8): 1248-1254, 2021 Aug 15.

Article en En | MEDLINE | ID: mdl-34512890

Palabras clave

Anti-tumor necrosis factor-α; Corticosteroids; Crohn's disease; Diabetes mellitus; Inflammatory bowel disease; Ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: World J Diabetes Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google